Mp88-09 Preclinical Model of Dual-Specific, Mtor Complex 1 (Torc1) and Mtor Complex 2 (Torc2) Inhibitors for Bladder Cancer Treatment

Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.2427
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Structural Insights of mTOR Complex 1

Cell Research
Cell BiologyMolecular Biology
2016English

Cryo-Em Structure of Human mTOR Complex 2

Cell Research
Cell BiologyMolecular Biology
2018English

The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2008English

ERK1/2 Phosphorylate Raptor to Promote Ras-Dependent Activation of mTOR Complex 1 (mTORC1)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

The Physiological mTOR Complex 1 Inhibitor DDIT4 Mediates Therapy Resistance in Glioblastoma

British Journal of Cancer
Cancer ResearchOncology
2019English

mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

mTOR Complex 1 Controls the Nuclear Localization and Function of Glycogen Synthase Kinase 3β

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

Dual Inhibition of PI3K and mTOR as an Alternative Treatment for Kaposi's Sarcoma

Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy